The effect of black tea on blood pressure: A systematic review with meta-analysis of randomized controlled trials

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Greyling, Arno ^a,b   Ras, Rouyanne T ^a   Zock, Peter L ^a,c   Lorenz, Mario ^d,e   Hopman, Maria T ^b   Thijssen, Dick H J ^b,f   Draijer, Richard ^a  

^a UNILEVER RESEARCH VLAARDINGEN   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^f LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLACK TEA EXTRACT; CAFFEINE; FLAVONOID; TEA;

BLOOD PRESSURE; CARDIOVASCULAR RESPONSE; CARDIOVASCULAR RISK; DIASTOLIC BLOOD PRESSURE; DIETARY INTAKE; HUMAN; HYPERTENSION; INTERVENTION STUDY; META ANALYSIS; PLANT LEAF; REVIEW; RISK REDUCTION; SCORING SYSTEM; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TEA; RANDOMIZED CONTROLLED TRIAL (TOPIC);

BLOOD PRESSURE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TEA;

EID: 84905396072     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103247     Document Type: Review

References (49)

1. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, et al. (2013) 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 31: 1281-1357.
2. World Health Organization (2009) Global health risks: mortality and burden of disease attributable to selected major risks. Available: http://www.who.int/healthinfo/global-burden-disease/GlobalHealthRisks-report- full.pdf.
3. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360: 1903-1913. (Pubitemid 35472129)
4. Rose G (2001) Sick individuals and sick populations. Int J Epidemiol 30: 427-432.
5. Peterson JJ, Dwyer JT, Jacques PF, McCullough ML (2012) Associations between flavonoids and cardiovascular disease incidence or mortality in European and US populations. Nutr Rev 70: 491-508.
6. Cassidy A, O'Reilly EJ, Kay C, Sampson L, Franz M, et al. (2011) Habitual intake of flavonoid subclasses and incident hypertension in adults. Am J Clin Nutr 93: 338-347.
7. Kay CD, Hooper L, Kroon PA, Rimm EB, Cassidy A (2012) Relative impact of flavonoid composition, dose and structure on vascular function: a systematic review of randomised controlled trials of flavonoid-rich food products. Mol Nutr Food Res 56: 1605-1616.
8. Song WO, Chun OK (2008) Tea is the major source of flavan-3-ol and flavonol in the U.S. diet. J Nutr 138: 1543S-1547S.
9. Vogiatzoglou A, Mulligan AA, Luben RN, Lentjes MA, Heiss C, et al. (2013) Assessment of the dietary intake of total flavan-3-ols, monomeric flavan-3-ols, proanthocyanidins and theaflavins in the European Union. Br J Nutr 1-11.
10. Zamora-Ros R, Knaze V, Romieu I, Scalbert A, Slimani N, et al. (2013) Impact of thearubigins on the estimation of total dietary flavonoids in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Eur J Clin Nutr 67: 779-782.
11. Hodgson JM, Croft KD (2010) Tea flavonoids and cardiovascular health. Mol Aspects Med 31: 495-502.
12. Stensvold I, Tverdal A, Solvoll K, Foss OP (1992) Tea consumption. relationship to cholesterol, blood pressure, and coronary and total mortality. Prev Med 21: 546-553.
13. Grassi D, Mulder TP, Draijer R, Desideri G, Molhuizen HO, et al. (2009) Black tea consumption dose-dependently improves flow-mediated dilation in healthy males. J Hypertens 27: 774-781.
14. Grassi D, Draijer R, Desideri G, Mulder T, Ferri C (2012) Abstract P061: Effects of Black Tea With and Without a Fat Load on Vascular Function in Mildly Hypertensive Subjects. Circulation 125: AP061.
15. Hodgson JM, Puddey IB, Woodman RJ, Mulder TP, Fuchs D, et al. (2012) Effects of black tea on blood pressure: a randomized controlled trial 2. Arch Intern Med 172: 186-188.
16. Hooper L, Kroon PA, Rimm EB, Cohn JS, Harvey I, et al. (2008) Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr 88: 38-50. (Pubitemid 351988681)
17. Mukamal KJ, MacDermott K, Vinson JA, Oyama N, Manning WJ, et al. (2007) A 6-month randomized pilot study of black tea and cardiovascular risk factors. Am Heart J 154: 724-726.
18. Schreuder THA, Eijsvogels TMH, Greyling A, Draijer R, Hopman MTE, et al. (2013) Effect of black tea consumption on brachial artery flow mediated dilation and ischaemia-reperfusion in humans. Appl Physiol Nutr Metab. doi: 10.1139/apnm-2012-0450.
19. Taubert D, Roesen R, Schoemig E (2007) Effect of cocoa and tea intake on blood pressure - A meta-analysis. Archives of Internal Medicine 167: 626-634. (Pubitemid 46603652)
20. Rakic V, Beilin LJ, Burke V (1996) Effect of coffee and tea drinking on postprandial hypotension in older men and women. Clin Exp Pharmacol Physiol 23: 559-563. (Pubitemid 26186440)
21. Verhagen AP, de Vet HC, de Bie RA, Kessels AG, Boers M, et al. (1998) The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol 51: 1235-1241. (Pubitemid 29009523)
22. Ras RT, Zock PL, Draijer R (2011) Tea consumption enhances endothelial-dependent vasodilation; a meta-analysis. PLoS One 6: e16974.
23. Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10: 101-129.
24. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560. (Pubitemid 37088507)
25. Egger M, Davey SG, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634. (Pubitemid 27387172)
26. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188. (Pubitemid 17189972)
27. van Houwelingen HC, Arends LR, Stijnen T (2002) Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med 21: 589-624. (Pubitemid 34141379)
28. Follmann D, Elliott P, Suh I, Cutler J (1992) Variance imputation for overviews of clinical trials with continuous response. J Clin Epidemiol 45: 769-773.
29. Thompson SG, Sharp SJ (1999) Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med 18: 2693-2708. (Pubitemid 29481404)
30. Thompson SG, Higgins JP (2002) How should meta-regression analyses be undertaken and interpreted? Stat Med 21: 1559-1573. (Pubitemid 34746063)
31. Duffy SJ, Keaney JF, Jr., Holbrook M, Gokce N, Swerdloff PL, et al. (2001) Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation 104: 151-156. (Pubitemid 32655830)
32. Hodgson JM, Puddey IB, Burke V, Beilin LJ, Jordan N (1999) Effects on blood pressure of drinking green and black tea. J Hypertens 17: 457-463. (Pubitemid 29308554)
33. Hodgson JM, Puddey IB, Burke V, Watts GF, Beilin LJ (2002) Regular ingestion of black tea improves brachial artery vasodilator function. Clin Sci (Lond) 102: 195-201. (Pubitemid 34185047)
34. Bingham SA, Vorster H, Jerling JC, Magee E, Mulligan A, et al. (1997) Effect of black tea drinking on blood lipids, blood pressure and aspects of bowel habit. Br J Nutr 78: 41-55. (Pubitemid 27345981)
35. Hodgson JM, Devine A, Puddey IB, Chan SY, Beilin LJ, et al. (2003) Tea intake is inversely related to blood pressure in older women. J Nutr 133: 2883-2886. (Pubitemid 37099776)
36. Arab L, Liu W, Elashoff D (2009) Green and black tea consumption and risk of stroke: a meta-analysis. Stroke 40: 1786-1792.
37. Larsson SC, Virtamo J, Wolk A (2013) Black tea consumption and risk of stroke in women and men. Annals of epidemiology 23: 157-160.
38. Shen L, Song LG, Ma H, Jin CN, Wang JA, et al. (2012) Tea consumption and risk of stroke: a dose-response meta-analysis of prospective studies. Journal of Zhejiang University SCIENCE B 13: 652-662.
39. Dharmashankar K, Widlansky ME (2010) Vascular endothelial function and hypertension: insights and directions. Curr Hypertens Rep 12: 448-455.
40. Fitzpatrick DF, Hirschfield SL, Ricci T, Jantzen P, Coffey RG (1995) Endothelium-dependent vasorelaxation caused by various plant extracts. J Cardiovasc Pharmacol 26: 90-95.
41. Grassi D, Aggio A, Onori L, Croce G, Tiberti S, et al. (2008) Tea, flavonoids, and nitric oxide-mediated vascular reactivity. J Nutr 138: 1554S-1560S.
42. Aburto NJ, Hanson S, Gutierrez H, Hooper L, Elliott P, et al. (2013) Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses. BMJ 346: f1378.
43. Dong JY, Tong X, Wu ZW, Xun PC, He K, et al. (2011) Effect of soya protein on blood pressure: a meta-analysis of randomised controlled trials. Br J Nutr 106: 317-326.
44. He FJ, Li J, Macgregor GA (2013) Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials. BMJ 346: f1325.
45. Ried K, Sullivan TR, Fakler P, Frank OR, Stocks NP (2012) Effect of cocoa on blood pressure. Cochrane Database Syst Rev 8: CD008893.
46. McCullough ML, Peterson JJ, Patel R, Jacques PF, Shah R, et al. (2012) Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults. Am J Clin Nutr 95: 454-464.
47. Nuesch E, Trelle S, Reichenbach S, Rutjes AW, Tschannen B, et al. (2010) Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study. BMJ 341: c3515.
48. Sterne JA, Gavaghan D, Egger M (2000) Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol 53: 1119-1129.
49. Astill C, Birch MR, Dacombe C, Humphrey PG, Martin PT (2001) Factors affecting the caffeine and polyphenol contents of black and green tea infusions. J Agric Food Chem 49: 5340-5347. (Pubitemid 33089675)